Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
While governments in at least 20 other states obtained more than 30 million doses of the drug through donations from the federal reserve or private companies, Oklahoma and Utah instead bought them from private pharmaceutical companies. Top officials in both states chalked up the decisions to “the fog of war.”  Oklahoma Gov. Kevin Stitt on Tuesday defended the state’s $2 million purchase, saying the drug was showing some promise. His health secretary attributed buying the 1.2 million hydroxychloroquine pills to something that happens in the “fog of war.”  Utah Gov. Gary Herbert at first defended the state’s $800,000 purchase of 20,000 packets of hydroxychloroquine compounded with zinc, but has since ordered an investigation of a no-bid contract with a local company that had been promoting the drugs. Herbert, a Republican, also canceled an additional plan to spend $8 million more to buy 200,000 additional treatments from the same company. A left-leaning nonprofit group in Utah filed a price gouging complaint Tuesday with state regulators, arguing the $40 per pack drug was grossly overpriced. Oklahoma’s attorney general requested an investigative audit on Tuesday of its Department of Health over spending and warned the agency about retaliating against employees who report wrongful government activities under the state’s Whistleblower Act. A spokesman for Attorney General Mike Hunter declined to comment on whether the request was related to the $2 million spent on the drug. Doctors can already prescribe the malaria drug to patients with COVID-19, a practice known as off-label prescribing, and many do. But the U.S. Food and Drug Administration on Friday warned doctors against prescribing hydroxychloroquine for treating the coronavirus outside of hospitals or research settings because of reports of serious side effects, including irregular heart rhythms and death among patients. Preliminary results from a recent study done on coronavirus patients at U.S. veterans hospitals showed no benefit, casting more doubt on the drug’s efficacy during the pandemic. Those were the latest admonitions against the drug that Trump has regularly promoted in public appearances, touting its potential despite his own health advisors telling him it is unproven. Oklahoma acquired 1.2 million pills, or about 100,000 doses, on April 4 from FFF Enterprises, a California-based medical supply wholesaler, according to the Oklahoma State Department of Health. Oklahoma state Rep. Melissa Provenzano, a Democrat from Tulsa, said the state’s purchase shows that Gov. Stitt’s actions don’t follow his claim that he relies on data to drive his decisions. “Two million dollars is a lot of money to waste, especially when we have unemployment claims approved yet going unpaid, health care professionals without proper protective equipment, and diagnosed cases and deaths continuing to rise,” Provenzano said. Stitt, a first-term Republican, said hydroxychloroquine was showing some promise as a treatment in early March, and he didn’t want Oklahoma to miss out on an opportunity to acquire it. “Now there’s some evidence the chloroquine may not be as effective, but I was being proactive to try and protect Oklahomans,” Stitt said Tuesday when asked about the purchase. “That’s always going to be my first instinct, to get the equipment and things we need that I’m seeing in the future would help Oklahomans.” Oklahoma’s Secretary of Health Jerome Loughridge said several physicians, including some in Oklahoma, were previously optimistic about the drug’s promise in treating COVID-19. He added that the drug is also useful for treating lupus and some other auto-immune diseases, so the state’s supply “will not have gone to waste.” “When we were battling sort of the fog of war at that point, we certainly acquired it on the potential that it would have utility,” Loughridge said. Jeff Burton, a former adjutant general of the Utah National Guard chosen to lead the state health department’s coronavirus task force, offered a similar explanation for why the state made its purchase. He said the state never received the pills and is trying to get its money back. “I chalk it up to fog of war,” Burton told the state’s pharmacy board. “There was a lot going on. It’s easy to judge it from (an) easy chair.. . . Since then we’ve decided that was not a wise purchase.”  Doctors in Oklahoma have been using the drug to treat patients with COVID-19, often in conjunction with a second drug, azithromiocin, but the results “just are not that promising,” said Dr. Douglas Drevets, chief of infectious diseases at University of Oklahoma Medicine. FFF Enterprises said it’s the company’s policy not to comment on transactions with customers. Utah gave a local company called Meds in Motion the $800,000 contract without taking bids from other companies under emergency procurement rules, said Christopher Hughes, director of Utah’s division of purchasing. State officials haven’t explained why they didn’t seek to get the drugs for free. The Federal Emergency Management Agency said Saturday it has sent out 28.6 million tablets of hydroxychloroquine sulfate free of cost to states around the country. Several states including New York, Connecticut and Texas received donations of the medication from a private company based in New Jersey called Amneal Pharmaceutical, according to information compiled by The Associated Press. Utah taxpayers deserve to know what happened to allow a purchase that seems like a company taking advantage of the early, chaotic days of the pandemic, said Chase Thomas, executive director of the group called Alliance for a Better Utah that submitted the price gouging complaint. The complaint alleges Utah paid at least double the common price for the medication. “Whether they were buying drugs we didn’t need or paying too much for it when they could have gotten them for free, there just needed to be a lot more thought going into this,” Thomas said. Meds in Motion didn’t answer an email seeking comment about the allegations. Herbert declined to provide an update Tuesday about the investigation of the purchase. He said Friday the state’s legal counsel would aim to find out what, how and why it happened. He said he believed state officials acted in good faith as they scrambled to slow the spread of coronavirus, but acknowledged a mistake may have been made. “I have some questions about how it came about,” Herbert said Friday. “Bottom line is, we’re not purchasing any more of this drug.”  ___ McCombs and Whitehurst reported from Salt Lake City.

Ex Output:
Oklahoma, Utah face scrutiny over malaria drug purchases.


Ex Input:
Seasoned explorer Robert Swan and his 23-year-old son Barney will begin their eight week, 600-mile expedition on Wednesday, hoping to show renewable energy can work in extreme conditions and prove a viable alternative to fossil fuels. “For the first time in history we will be surviving only on renewable energy. It’s never been done,” 61-year-old polar veteran Swan, the first person to walk to both the North and South poles, told Reuters. The Swans’ 5,000 daily calorie intake will come from sustainable and energy-giving foods, such as grains and almond bars, to help them overcome temperatures of -40 degrees Celsius and the obvious risks of frostbite, altitude sickness and snow blindness. Perpetual sunlight will charge the solar panels, which will power a NASA-designed ice melter to provide them with enough water for drinking and cooking. “Water is gold down in Antarctica, without it you’re going to be dying pretty quickly, as dad always reminds me,” said Barney Swan. While their aim is to complete the trek using just solar energy, under extreme weather conditions they’ll turn to an advanced biofuel made out of wood chip waste. “The fuels have been tested to minus 60 degrees Celsius...it won’t get as cold as minus 60. We may get minus 40 which is, trust me, cold enough,” the elder Swan said.

Ex Output:
Father-son team plans Antarctic trek powered by renewable energy.


Ex Input:
"Republican Party of Virginia Chairman Pat Mullins kicked off the New Year attacking recent side effects of health care overhaul on Flexible Spending Accounts, which allow workers to pay medical expenses with pre-tax dollars. In an e-letter titled ""FSA at Work? Jim Webb Just Made It a Lot Less Useful,"" Mullins staples Virginia’s senior Senator to new provisions of the health care law that took effect Jan. 1. ""Desperate for tax dollars to pay for their $1 trillion health care takeover, Nancy Pelosi, Barack Obama, and Jim Webb decided to pick the pockets of consumers who opted to take responsibility for their own health care costs and remove the ability of consumers to use FSA and HSA plans to pay for things like aspirin and other non-prescription health needs,"" Mullins wrote. He later reiterates the point, writing: ""Until this week, consumers could use their accounts to set aside pre-tax money for medical expenses. But thanks to Webb and other tax happy Democrats, over-the-counter drug purchases are now off limits to FSA and HSA accounts."" There’s plenty of confusion about health care reform, so we checked to see if his claim about over-the-counter drugs is correct. As a source, Mullins cited a news report from KSAT 12 out of San Antonio, Texas. The report says, ""Over-the-counter medications will no longer be reimbursable through a health care flexible spending account, or FSA, even if the account has a grace period. So, Dec. 31 is the last day to stock up on pain relievers, allergy tablets, antacids and more for people who want to use them to exhaust their use-it-or-lose-it FSA."" Not convinced San Antonio’s KSAT 12 is an end-all source for health care reform, we dug deeper. According to the Internal Revenue Service guidance on flexible spending accounts, a new provision ""as added by the Affordable Care Act, provides that...beginning after December 31, 2010, expenses incurred for a medicine or a drug shall be treated as a reimbursement for medical expenses only if such medicine or drug is a prescribed drug (determined without regard to whether such drug is available without a prescription) or is insulin."" In other words, you will no longer be able to use FSAs to pay for your aspirin, antacids and other over-the-counter drugs if they’re not prescribed by a physician. What about HSAs -- tax-advantaged health savings accounts? Pretty much the same. The IRS says that ""a distribution from an HSA...for a medicine or drug is a tax-free qualified medical expense only if (1) the medicine or drug requires a prescription, (2) is an over-the-counter medicine or drug and the individual obtains a prescription, or (3) is insulin."" Otherwise, those ""non-qualified expenses"" will be taxed at 20 percent rather than the current 10 percent for HSA plan participants. So, while the recently enacted portion of the health care law will not stop consumers from being able to buy over-the-counter drugs through their plans, it will require a prescription to do so. On that count, Mullins stays relatively safe by employing the phrase ""non-prescription health needs"" at the end of his claim. , those items like aspirin can still qualify for reimbursement with a prescription, but then they would not longer be ""non-prescription."" But the same phrase also presents a problem for Mullins because other ""non-prescription"" items such as medical supplies and first-aid items remain eligible for reimbursement without a prescription. ""Over-the-counter medications are treated differently than over-the-counter medical items like Band-Aids, which are covered without a prescription,"" said Michael Waxman of Save Flexible Spending Plans. If you’re wondering why these changes are taking place, the answer is likely money. ""I think [federal officials] were just looking for revenue raisers,"" Mike Thompson, a human resource services principal with the PwC recently told the Washington Post. As that story notes, employee contributions to FSAs are made on a pretax basis, reducing earnings and thus the amount workers pay in income tax. According to the Joint Committee on Taxation, tightening up the tax break on over-the-counter purchases will generate an estimated $5 billion in federal revenues through 2019. And one last note: Webb, as Mullins said, did vote for the massive health care reform bill that limits the use of flexible spending accounts. Let’s look back. Mullins says health care law provisions that took effect Jan. 1 will ""remove the ability of consumers to use FSA and HSA plans to pay for things like aspirin and other non-prescription health needs."" It’s  that as of Jan. 1, FSA and HSA plans no longer offered reimbursements for over-the-counter drugs without a prescription. However, those same items could be covered with a prescription. Mullins misses a caveat by not noting that non-prescription items like crutches, bandages, and health supplies like diagnostic devices and blood sugar test kits remain covered. But his comments seem directed at drugs. We find his claim ."

Ex Output:

New provisions of the health care law bar the use of flexible spending accounts and health savings accounts to pay for aspirin and other non-prescription health needs.